GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TP63 | hg38_v1_chr3_+_189789734_189789801 | -0.55 | 2.4e-18 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 79.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
2.5 | 61.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
3.0 | 60.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
1.2 | 48.1 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.9 | 45.9 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
3.1 | 40.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
2.8 | 36.7 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
3.6 | 32.7 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
10.4 | 31.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.5 | 31.0 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 70.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
4.3 | 69.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.4 | 62.7 | GO:0005882 | intermediate filament(GO:0005882) |
15.1 | 45.4 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
4.2 | 41.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
4.6 | 41.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
2.2 | 40.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
2.3 | 35.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 34.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
6.5 | 32.7 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 79.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
4.9 | 79.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
2.6 | 56.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 51.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
7.2 | 36.1 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
6.5 | 32.7 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
10.4 | 31.3 | GO:0098808 | mRNA cap binding(GO:0098808) |
5.7 | 28.7 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
7.0 | 27.9 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.9 | 26.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 62.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.7 | 62.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.8 | 59.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 40.9 | PID P73PATHWAY | p73 transcription factor network |
2.3 | 32.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 32.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.7 | 28.7 | PID MYC PATHWAY | C-MYC pathway |
0.4 | 26.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 25.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 22.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 78.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
1.3 | 61.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.8 | 60.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.8 | 59.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
1.6 | 45.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.6 | 32.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.4 | 31.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.8 | 29.0 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
1.3 | 28.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 23.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |